Kinkini Gupta
... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Written By: Kinkini Gupta | Updated : January 26, 2023 12:21 PM IST
Covishield Booster Dose Offers The Strongest Immune Response, Lancet Study
The Covishield booster dose, manufactured by the Serum Institute of India Pvt Ltd (SII) in India has been reported to have the best immune response to any emerging COVID-19 threat. A study was conducted published by the Lancet Regional Health Southeast Asia journal reveled that irrespective of the patient's primary which could be Covishield or Covaxin, it has been found that Covishield booster dose has the best immune response.
According to the study, experts witnessed better binding and functional antibodies when a person was given the booster dose of this particular vaccine. They reported that the immune response in this vaccine was better than any other. This revelation comes irrespective of the fact that homologous and heterologous boosting with Covishield or Covaxin in Covishield or Covaxin primed individuals are immunogenic and safe.
Researchers from Christian Medical College in Vellore, Tamil Nadu and Centre for Cellular and Molecular Biology, Hyderabad, Andhra Pradesh are the ones who conducted this study and found the results. In the study, their aim was to understand the immunogenicity and safety of homologous heterologous vaccination through the medium of Covaxin and Covishield. These two are among the most primary vaccines that were administered among majority of the Indian population during the peak of COVID-19 infections spread.
As per the observations made by experts, the primary SARS-CoV-2 vaccination wanes over time and that is resulting in depletion of an individual's immune response that should ideally be able to fight new variants of coronavirus. This is risky at a time when the world is witnessing the emerging of new COVID- variants every year. And each year the variants are being reported to be deadlier than the last one. At such a point a booster dose of the vaccine becomes imperative. The World Health Organization (WHO) has highly recommended the administration of booster doses. Moreover, a booster dose would ensure extra precautions and protection against these emerging and highly transmissible variants.
